📊 Score Breakdown
Offering Ability
46
Cash Runway
65
Float Risk
5
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
7%
💰 Capital Raise
15%
• Under 12 months cash (10mo)
💹 Market Data
Market CapN/A
Shares Outstanding86.24M
FloatN/A
Cash$19.75M
Debt$2.20M
Short InterestN/A
🏛 Institutional Holdings
Institutional data not yet available.
📉 Short Interest
Short Interest80
Days to Cover1.0
% of FloatN/A
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Dec 31, 2024
xbrl
XBRL CONVERTIBLE
Dec 31, 2016
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔗 Related Stocks — MEDIUM Risk
Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:
🔬 More Research for EYES
📊 EYES FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 EYES Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.